Final analysis of relapse-free survival in a multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine after resection of high-risk melanoma.

被引:1
|
作者
Slingluff, Craig L.
Blumenstein, Brent A.
Lewis, Karl D.
Andtbacka, Robert Hans Ingemar
Hyngstrom, John Robert
Milhem, Mohammed M.
Markovic, Svetomir
Hamid, Omid
Hernandez-Aya, Leonel Fernando
Bowles, Tawnya Lynn
Philips, Prejesh
Jang, Sekwon
Lutzky, Jose
Bar, Anna
Beitsch, Peter D.
机构
[1] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[2] Trial Architecture Consulting, Washington, DC USA
[3] Univ Colorado Denver, Sch Med, Aurora, CO USA
[4] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[5] Univ Utah, Salt Lake City, UT USA
[6] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
[7] Mayo Clin, Rochester, MN USA
[8] Angeles Clin & Res Inst, Los Angeles, CA USA
[9] Univ Michigain Hlth Syst, Ann Arbor, MI USA
[10] Intermt Med Ctr, Murray, UT USA
[11] Univ Louisville, Louisville, KY 40292 USA
[12] Inova Schar Canc Inst, Fairfax, VA USA
[13] Mt Sinai Med Ctr, Miami Beach, FL 33140 USA
[14] OHSU Knight Canc Inst, Portland, OR USA
[15] Dallas Surg Grp, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10017
引用
收藏
页数:2
相关论文
共 50 条
  • [21] A Phase II Multicenter Double-Blind Placebo-Controlled Study of Ethyl Pyruvate in High-Risk Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
    Bennett-Guerrero, Elliott
    Swaminathan, Madhav
    Grigore, Alina M.
    Roach, Gary W.
    Aberle, Laura G.
    Johnston, Jeffrey M.
    Fink, Mitchell P.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2009, 23 (03) : 324 - 329
  • [22] Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial (vol 16, pg 522, 2015)
    Eggermont, A. M. M.
    Chiarion-Sileni, V
    Grob, J-J
    LANCET ONCOLOGY, 2015, 16 (06) : E262 - E262
  • [23] A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial
    Bashir, Qaiser
    Nishihori, Taiga
    Pasquini, Marcelo C.
    Martens, Michael J.
    Wu, Juan
    Alsina, Melissa
    Anasetti, Claudio
    Brunstein, Claudio
    Dawson, Peter
    Efebera, Yvonne
    Gasparetto, Cristina
    Geller, Nancy
    Giralt, Sergio
    Hall, Aric C.
    Koreth, John
    McCarthy, Philip
    Scott, Emma
    Stadtmauer, Edward A.
    Vesole, David H.
    Hari, Parameswaran
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 358e1 - 358e7
  • [24] Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
    Schimanski, Carl Christoph
    Kasper, Stefan
    Hegewisch-Becker, Susanna
    Schroeder, Jan
    Overkamp, Friedrich
    Kullmann, Frank
    Bechstein, Wolf Otto
    Voehringer, Matthias
    Oellinger, Robert
    Lordick, Florian
    Heinemann, Volker
    Geissler, Michael
    Schulz-Abelius, Armin
    Bernhard, Helga
    Schoen, Michael R.
    Greil, Richard
    Galle, Peter
    Lang, Hauke
    Schmidtmann, Irene
    Moehler, Markus
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [25] Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
    Cuzick, Jack
    Sestak, Ivana
    Forbes, John F.
    Dowsett, Mitch
    Knox, Jill
    Cawthorn, Simon
    Saunders, Christobel
    Roche, Nicola
    Mansel, Robert E.
    von Minckwitz, Gunter
    Bonanni, Bernardo
    Palva, Tiina
    Howell, Anthony
    LANCET, 2014, 383 (9922) : 1041 - 1048
  • [26] Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. (vol 16, pg 522, 2015)
    Eggermont, A. M. M.
    Chiarion-Sileni, V
    Grob, J-J
    LANCET ONCOLOGY, 2016, 17 (06) : E223 - E223
  • [27] Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study
    Maschmeyer, G.
    Heinz, W. J.
    Hertenstein, B.
    Horst, H. -A.
    Requadt, C.
    Wagner, T.
    Cornely, O. A.
    Loeffler, J.
    Ruhnke, M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (05) : 679 - 689
  • [28] Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study
    G. Maschmeyer
    W. J. Heinz
    B. Hertenstein
    H.-A. Horst
    C. Requadt
    T. Wagner
    O. A. Cornely
    J. Löffler
    M. Ruhnke
    European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 679 - 689
  • [29] Efficacy of Lidocaine Infusion in High-Risk Vascular Surgery-A Randomized, Double-Blind, Placebo-Controlled Single-Center Clinical Trial
    Gajniak, Dariusz
    Mendrala, Konrad
    Cyzowski, Tomasz
    Polak, Michal
    Gierek, Danuta
    Krzych, Lukasz J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [30] The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial
    Shahriari, Ali
    Karimi, Elham
    Shahriari, Mohammadali
    Aslani, Neda
    Khooshideh, Maryam
    Arab, Arman
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141